Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

88.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.9K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.5K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

5.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.5K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

3.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA-G regulatory variants and haplotypes with susceptibility to recurrent pregnancy loss.

International journal of immunogenetics·2018
Same author

Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Genes, brain, and behavior·2017
Same author

Sci-Thurs PM: Delivery-01: Sliding Window IMRT: Uncertainties of the leading edge and plateau of the beam profile.

Medical physics·2017
Same author

Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test.

Genes, brain, and behavior·2016
Same author

Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.

Dento maxillo facial radiology·2014
Same author

Association between MIF gene variation and Meniere's disease.

International journal of immunogenetics·2013

Related Experiment Video

Updated: Mar 29, 2026

Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience
08:14

Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience

Published on: August 26, 2014

12.2K

RNA-binding proteins, neural development and the addictions.

C D Bryant1, N Yazdani1

  • 1Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, MA, USA.

Genes, Brain, and Behavior
|December 9, 2015
PubMed
Summary

RNA-binding proteins (RBPs) regulate gene expression, impacting brain development and function. Understanding RBP roles in addiction is crucial for developing targeted therapies.

Keywords:
AmphetamineRNA-binding proteindopaminegenetichnRNPneurodevelopmentalopioidpsychostimulantsubstance abusesubstance use disorder

More Related Videos

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
06:18

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

13.6K
Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77
12:30

Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77

Published on: August 17, 2015

7.9K

Related Experiment Videos

Last Updated: Mar 29, 2026

Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience
08:14

Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience

Published on: August 26, 2014

12.2K
Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
06:18

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

13.6K
Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77
12:30

Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77

Published on: August 17, 2015

7.9K

Area of Science:

  • Neurobiology
  • Genetics
  • Molecular Biology

Background:

  • Gene expression regulation, at both transcriptional and post-transcriptional levels, is key to understanding neurobiological mechanisms linking genetic/environmental risks to addiction-related neurobehavioral dysfunction.
  • RNA-binding proteins (RBPs) are crucial regulators of RNA biogenesis, with over 50% expressed in the brain, influencing RNA processing, transport, stability, and translation throughout life.
  • RBP dysfunction is implicated in various neurological disorders, including neurodegenerative (Alzheimer's, Parkinson's) and neurodevelopmental (autism, schizophrenia) conditions.

Purpose of the Study:

  • To review the evidence linking RNA-binding proteins (RBPs) to critical molecular targets, neurodevelopment, synaptic plasticity, and the neurobehavioral dysfunction associated with addiction.
  • To highlight the growing importance of genome-wide association studies and advanced transcriptomic/proteomic techniques in identifying RBP functions in addiction.
  • To outline the challenges and future directions in understanding RBP targetomes and leveraging post-transcriptional modifications for therapeutic interventions in addiction.

Main Methods:

  • Literature review and synthesis of existing research on RNA-binding proteins (RBPs) and their role in neurobiology.
  • Analysis of findings from genome-wide association studies (GWAS) in humans and model organisms.
  • Integration of transcriptomic and proteomic data to understand RBP functions and target interactions.

Main Results:

  • RNA-binding proteins (RBPs) play significant roles in regulating gene expression relevant to neurodevelopment, synaptic plasticity, and addiction.
  • Dysfunctional RBPs can contribute to a range of neurological and neurodevelopmental disorders, suggesting their broader impact on brain health.
  • Advanced genomic and molecular techniques are increasingly revealing specific RBP functions in the context of addiction.

Conclusions:

  • RNA-binding proteins (RBPs) are critical regulators influencing neurobiological pathways implicated in addiction.
  • Further research is needed to elucidate the dynamic and cell-type-specific functions of RBP targetomes.
  • Targeting RBP-mediated post-transcriptional modifications offers a potential therapeutic strategy for preventing or reversing addiction-related neurobiological changes.